We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Quantitative adverse outcome pathway (qAOP) models for toxicity prediction
Summary
This review examines the developing concept of quantitative adverse outcome pathways (qAOPs) — computational models linking molecular initiating events to population-level harm — and proposes a framework for their development, validation, and use in chemical risk assessment.
The quantitative adverse outcome pathway (qAOP) concept is gaining interest due to its potential regulatory applications in chemical risk assessment. Even though an increasing number of qAOP models are being proposed as computational predictive tools, there is no framework to guide their development and assessment. As such, the objectives of this review were to: (i) analyse the definitions of qAOPs published in the scientific literature, (ii) define a set of common features of existing qAOP models derived from the published definitions, and (iii) identify and assess the existing published qAOP models and associated software tools. As a result, five probabilistic qAOPs and ten mechanistic qAOPs were evaluated against the common features. The review offers an overview of how the qAOP concept has advanced and how it can aid toxicity assessment in the future. Further efforts are required to achieve validation, harmonisation and regulatory acceptance of qAOP models.
Sign in to start a discussion.
More Papers Like This
The Development and Use of Adverse Outcome Pathways in Mechanistic Toxicology
This thesis explored Adverse Outcome Pathways (AOPs) as a structured mechanistic framework for understanding chemical toxicity without traditional animal testing. It covered AOP development, conceptual structure, and practical applications in modern toxicology, including for environmental contaminants like microplastics.
Adverse Outcomes Pathways (AOPs)
This review examines the concept of adverse outcome pathways (AOPs) and their application to environmental health risk assessment, including the prediction of microplastic toxicity through data mining approaches. Researchers found that AOPs can support the reduction of animal testing by identifying data gaps and guiding the development of in silico and in vitro tests for toxicity prediction.
Development of AOP relevant to microplastics based on toxicity mechanisms of chemical additives using ToxCast™ and deep learning models combined approach
Researchers used ToxCast high-throughput screening data and deep learning models to build adverse outcome pathway (AOP) models for common plastic additive chemicals, identifying molecular initiating events and potential health endpoints relevant to human and environmental microplastic toxicity.
Expanding adverse outcome pathways towards one health models for nanosafety
This study proposes expanding adverse outcome pathway frameworks to incorporate One Health models for nanomaterial safety assessment. The research suggests that connecting chemical safety assessment, epidemiology, and ecology through a holistic multiscale approach could better evaluate the risks of nano-enabled products for both humans and the environment.
In vivo , in vitro , and in silico toxicology studies of nanoplastics and their modeling
This in vivo, in vitro, and in silico study assessed nanoplastic toxicity through multiple complementary methods, finding concentration-dependent toxic effects on cellular and organismal endpoints and using computational modeling to predict interaction mechanisms relevant to nanoplastic risk assessment.